Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype
Citation
Porter , R J , Murray , G I , Price , D P , Petty , R D & McLean , M H 2020 , ' Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype ' , British Journal of Cancer , vol. 122 , pp. 545-554 . https://doi.org/10.1038/s41416-019-0685-1